1. Huang XZ, Gao P, Wang ZN. Antibiotic Treatment and Immune Checkpoint Inhibitor Therapy in Patients With Cancer. JAMA Oncol. 2020 Apr 1;6(4):586-587. (IF=24.799)

2. Miao ZF , Sun JX , Mahliyah Adkins-Threats , Min-Jiao Pang , Jun-Hua Zhao , Xin Wang , Kai-Wen Tang , Wang ZN , Jason C Mills. DDIT4 licenses only healthy cells to proliferate during injury-induced metaplasia. Gastroenterology. 2020 Sep 18;S0016-5085(20)35164-7. (IF=17.373)

3. Xu Y, Li Y, Jin J, Han G, Sun C, Pizzi MP, Huo L, Scott A, Wang Y, Ma L, Lee JH, Bhutani MS, Weston B, Vellano C, Yang L, Lin C, Kim Y, MacLeod AR, Wang L, Wang Z, Song S, Ajani JA. LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma. Mol Cancer. 2019 Oct 10;18(1):141.（IF=15.302）

4. Zhang YZ, Zhao JH, Yu HB, Li P, Liang WF, Liu Z, Gwo-Bin Lee, Liu LQ, Li WJ, and Wang ZN. Detection and isolation of free cancer cells from ascites and peritoneal lavages using optically induced electrokinetics (OEK). Sci Adv. 2020 Aug 5;6(32):eaba9628. (IF=13.116)

5. Song YX, Sun JX, Zhao JH, Yang YC, Shi JX, Wu ZH, Chen XW, Gao P, Miao ZF, Wang ZN. Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion. Nat Commun. 2017 Aug 18;8(1):289. (IF=12.353)

6. Willet SG, Lewis MA, Miao ZF, Liu D, Radyk MD, Cunningham RL, Burclaff J, Sibbel G, Lo HG, Blanc V, Davidson NO, Wang ZN, Mills JC. Regenerative proliferation of differentiated cells by mTORC1-dependent paligenosis. EMBO J. 2018 Apr 3;37(7). pii: e98311. (IF=10.557)

7. Miao ZF, Lewis MA, Cho CJ, Adkins-Threats M, Park D, Brown JW, Sun JX, Burclaff JR, Kennedy S, Lu JY, Mahar M, Vietor I, Huber LA, Davidson NO, Cavalli V, Rubin DC, Wang ZN, Mills JC. A dedicated evolutionarily conserved molecular network licenses differentiated cells to return to the cell cycle. DEV CELL. 2020 Oct 26;55(2):178-194.e7. (IF=10.092)

8. Wen T, Wang ZN, Li Y, Li Z, Che XF, Fan YB, Wang S, Qu JL, Yang XH, Hou KZ, Zhou WY, Xu L, Li C, Wang J, Liu J, Chen LQ, Zhang JD, Qu XJ, Liu YP. A Four-Factor Immunoscore System that Predicts Clinical Outcome for Stage II/III Gastric Cancer. Cancer Immunol Res. 2017 Jul;5(7):524-534. (IF=9.188)